Volunteer for NIAID-funded clinical studies related to antimicrobial (drug) resistance on ClinicalTrials.gov.
Clinical research projects related to antibacterial resistance focus on the safety and effectiveness of new antimicrobial therapeutics, vaccines, diagnostics, and prevention strategies. In addition, NIAID supports a number of studies on optimizing use of existing drugs. An important goal of this research is to identify treatment regimens that limit the emergence of drug resistance, which is a growing problem in treating infectious diseases.
The NIAID clinical research program on antibacterial resistance includes both clinical studies and clinical trials. Clinical studies involve human subjects but typically do not test products or interventions. In contrast, clinical trials evaluate the safety and effectiveness of diagnostic, preventive, and therapeutic products or interventions in human subjects. NIAID supports clinical research through grants, cooperative agreements, and a variety of contracts, as well as clinical research services that support planning and conduct of clinical research and oversight activities for human subject protection.
Highlights include research in the following areas:
Further information about these and other NIAID-supported antimicrobial resistance research projects can be found using the RePORT (Research Portfolio Online Reporting Tools) website.
RePORT provides access to a variety of reporting tools, reports, data, and analyses of National Institutes of Health (NIH) research activities. One of the tools available on the RePORT site is the RePORTER (RePORT Expenditures and Results) module. RePORTER is an electronic tool that allows users to search a repository of NIH-funded research projects and access publications and patents resulting from NIH funding.
For more information on NIAID-supported antibacterial resistance research, please see
Last Updated March 11, 2014